New hope for Tough-to-Treat lung cancer patients
NCT ID NCT07306624
Summary
This study is testing whether adding an experimental drug called nelmastobart to standard chemotherapy (docetaxel) can help control advanced lung cancer. It's for patients whose cancer has continued to grow despite previous treatments like platinum-based chemotherapy or immunotherapy. The main goal is to see if this combination can slow cancer progression and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, South Korea
Contact
-
Korea University Anam Hospital
NOT_YET_RECRUITINGSeoul, South Korea
Contact
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
Contact
-
Seoul National University Bundang Hospital
NOT_YET_RECRUITINGSeoul, South Korea
Contact
-
The Catholic University of Korea St. Vincent's Hospital
NOT_YET_RECRUITINGGyeonggi-do, South Korea
Contact
Conditions
Explore the condition pages connected to this study.